Reconsidering current approaches to valve and LVAD therapies
Key topics:
-Epic Plus Mitral is a suitable platform for MICS delivering favourable outcomes – M. Loubani
-Better hemodynamic outcomes can be achieved with Epic Max – T. Holubec
-Surgical assessment and technical strategies to overcome more challenging patient characteristics when implanting LVADs – A. Loforte
-The impact of avoiding aspirin in HeartMate 3 LVAD patients: results from the ARIES trial – I.Netuka
Related Videos
A Defining Moment Has To Start Somewhere. Why Not With You?
Webinar for Collaborative Management of HF Patients with MR
M-TEER: Best treatment strategies for FMR AND DMR
M-TEER: State of the art echocardiography imaging modalities
AV VALVES Summit 2026 | Introduction
New clinical evidence and patient selection M-TEER therapy
Artifical intelligence in structural heart imaging
Anatomy for structural heart therapies
TRENDING TOPICS
Procedural tip & tricks with Navitor across all valve sizes
1-year VANTAGE TAVI outcomes in low/intermediate-risk patients
Transcatheter Aortic Valves Implant
